Pierre Beaurang

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Christine Ring, as Attorney-in-Fact for Pierre Beaurang
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pierre Beaurang:

Company Role Class Num Shares Value Price $ Report Date Ownership
Nurix Therapeutics, Inc. Chief Business Officer Common Stock 116,666 $1,167,022 $10.00 10 Aug 2021 By Trust
Nurix Therapeutics, Inc. Chief Business Officer Common Stock 4,330 $43,313 $10.00 10 Aug 2021 Direct
Nurix Therapeutics, Inc. Chief Business Officer Employee Stock Option (right to buy) 6,562 10 Aug 2021 Direct

Insider Reports Filed by Pierre Beaurang

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NRIX Nurix Therapeutics, Inc. 10 Aug 2021 4 -$215,601 4 Chief Business Officer 11 Aug 2021, 18:20
NRIX Nurix Therapeutics, Inc. 12 Jul 2021 4 -$171,094 4 Chief Business Officer 12 Jul 2021, 19:36
NRIX Nurix Therapeutics, Inc. 10 Jun 2021 5 -$211,923 4 Chief Business Officer 11 Jun 2021, 16:10
NRIX Nurix Therapeutics, Inc. 10 May 2021 5 -$190,319 4 Chief Business Officer 11 May 2021, 19:56